Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...

India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

AZ said adding YS2302018 to its pipeline strengthens its cardiovascular portfolio with a drug that could have potential in a ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Urogen Pharma (URGN – Research Report), with a ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

Executive appointments will drive growth strategy and progression of clinical pipeline Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat ...

Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...

No matter what happens, investing in companies that will get through bear markets and perform well over the long run is ...